Kalra Sanjay, Das A K, Kotwal Narendra, Nagendra Lakshmi, Agrawal Rashi, Ganesh H K, Das Sambit, Singh Arun Kumar, Kapoor Nitin, Dhingra Atul, Jain Abhilasha, Sharma Sourabh, Gupta Vinod, Verma Suneet Kumar, Sharma Hanjabam Barun, Prabhoo Ram, Shetty Naresh, Muchhala Sameer, Pinto Nimitha
Treasurer, International Society of Endocrinology (ISE); Vice President, South Asian Obesity Forum (SOF); Bharti Hospital, Karnal, Haryana, India, Orcid: https://orcid.org/0000-0003-1308-121X.
Dean Academic, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth, Puducherry, India.
J Assoc Physicians India. 2025 Jun;73(6):50-60. doi: 10.59556/japi.73.1031.
Sarcopenia, an age-related condition marked by the decline of skeletal muscle mass, strength, and function, often leads to loss of function, disability, and diminished quality of life (QoL) in the elderly population. Despite its growing prevalence, sarcopenia is frequently underdiagnosed and inadequately managed. Timely detection and appropriate interventions are crucial to slowing disease progression and minimizing associated risks. As standardized guidelines and individualized management plans are necessary to improve clinical outcomes, this consensus paper presents expert insights into advancements in sarcopenia management, including diagnostic criteria and therapeutic interventions, and the need for personalized screening tools for Indian demographics. Furthermore, experts emphasized the importance of a multimodal approach, integrating resistance exercise, nutritional optimization, and emerging pharmacological therapies for effective sarcopenia treatment. The role of anabolic agents such as nandrolone decanoate in muscle preservation is explored, alongside considerations for patient selection and safety. This paper underscores the importance of a patient-centered approach, which addresses both functional recovery and overall well-being of individuals at risk or diagnosed with sarcopenia.